Zomedica Completes Internal “Launch Team” for Upcoming TRUFORMA™ Commercialization
December 07, 2020 06:01 ET
|
Zomedica Corp.
ANN ARBOR, Mich., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...
Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA™
November 13, 2020 06:00 ET
|
Zomedica Corp.
ANN ARBOR, Mich., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...
Zomedica Announces Third Quarter 2020 Financial Results
November 12, 2020 06:30 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or “Company”) today reported consolidated financial results for the third quarter ended September...
Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Special Virtual-Only Meeting
October 26, 2020 09:25 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) announced today that the following letter from Robert Cohen, Interim Chief Executive Officer, has been made...
Zomedica Announces Name Change
October 02, 2020 17:05 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Oct. 02, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating...
Zomedica Announces Shareholder Meeting Voting Results
September 25, 2020 11:00 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics...
Zomedica Announces Letter to Shareholders in Connection With Annual and Special Virtual-Only Meeting
September 14, 2020 17:44 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) announced today that its proxy solicitor, Alliance Advisors, mailed the following letter to...
Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference
September 10, 2020 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), a veterinary health company creating point-of-care diagnostics products for companion...
Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA™
September 08, 2020 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) announced today that it has agreed with its development partner Qorvo Biotechnologies, LLC,...
Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Special Virtual-Only Meeting
August 27, 2020 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) announced today that the following letter from Robert Cohen, Interim Chief Executive Officer,...